![Mary Fenton](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mary Fenton
Director of Finance/CFO at
CULLINAN THERAPEUTICS, INC.
Net worth: 3 M $ as of 31/08/2026
Profile
Mary Kay Fenton is currently Director at Connecticut Business & Industry Association since 2018 and Chief Financial Officer at Cullinan Therapeutics, Inc. starting in 2024.
Former roles include Independent Director at Oncorus, Inc. from 2019 to 2023, Vice President-Strategic Operations at Vertex Pharmaceuticals, Inc. from 2019 to 2021, Senior Manager-Technology Industry Group at PricewaterhouseCoopers LLP from 1991 to 2000, CFO, Principal Accounting Officer & Executive VP at Achillion Pharmaceuticals, Inc. from 2016 to 2018, President, Chief Executive & Financial Officer at Talaris Therapeutics, Inc. in 2023, and Chief Operating & Financial Officer at Semma Therapeutics, Inc. in 2019.
Education includes undergraduate studies at College of the Holy Cross (Massachusetts) and an MBA from the University of Connecticut School of Business.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 30/06/2026 | 127,921 ( 0.22% ) | 3 M $ | 31/08/2026 |
Mary Fenton active positions
| Companies | Position | Start |
|---|---|---|
| CULLINAN THERAPEUTICS, INC. | Director of Finance/CFO | 29/04/2024 |
Connecticut Business & Industry Association
 Connecticut Business & Industry Association Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization that provides commercial support services | Director/Board Member | 06/12/2018 |
Former positions of Mary Fenton
| Companies | Position | End |
|---|---|---|
| TOUE BIOPAR | Chief Executive Officer | 01/10/2023 |
| ONCORUS, INC. | Director/Board Member | 27/07/2023 |
| VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01/02/2021 |
Semma Therapeutics, Inc.
 Semma Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative therapies for patients who currently depend on insulin injections | Director of Finance/CFO | 01/10/2019 |
| ACHILLION PHARMACEUTICALS, INC. | Director of Finance/CFO | 28/12/2018 |
Training of Mary Fenton
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
86
1st degree connections
10
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 10 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, tax and business consulting services | Commercial Services |
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes treatments for infectious diseases | Health Technology |
College of the Holy Cross (Massachusetts)
 College of the Holy Cross (Massachusetts) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Connecticut Business & Industry Association
Connecticut Business & Industry Association Miscellaneous Commercial ServicesCommercial Services Operates as a non profit organization that provides commercial support services | Commercial Services |
University of Connecticut School of Business
 University of Connecticut School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Talaris Therapeutics, Inc.
 Talaris Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Semma Therapeutics, Inc.
Semma Therapeutics, Inc. BiotechnologyHealth Technology Develops transformative therapies for patients who currently depend on insulin injections | Health Technology |
Oncorus, Inc.
 Oncorus, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops next generation immunotherapy platform to treat cancer | Health Technology |
Cullinan Oncology, Inc.
 Cullinan Oncology, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
- Stock Market
- Insiders
- Mary Fenton
